[ad_1]
NEW DELHI: Shares of Solar Pharmaceutical Industries fell by over 4 per cent in morning commerce on Tuesday a day after the corporate mentioned its consolidated internet loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, primarily on account of a one-time distinctive loss. The corporate’s inventory declined 4.12 per cent to Rs 851.50 on the BSE.
On the NSE, it tumbled 4.17 per cent to Rs 851.20 apiece.
The Mumbai-based drug main on Monday reported a internet revenue of Rs 894 crore within the January-March interval of 2020-21.
Consolidated gross sales from operations stood at Rs 9,386 crore within the fourth quarter.
The corporate had reported gross sales from operations at Rs 8,464 crore within the year-ago interval.
Through the interval underneath evaluation, the corporate mentioned it incurred a one-time value of Rs 56.35 crore for restructuring operations in sure nations.
Whole loss cited as an distinctive merchandise through the fourth quarter, stood at Rs 3,936 crore.
On the NSE, it tumbled 4.17 per cent to Rs 851.20 apiece.
The Mumbai-based drug main on Monday reported a internet revenue of Rs 894 crore within the January-March interval of 2020-21.
Consolidated gross sales from operations stood at Rs 9,386 crore within the fourth quarter.
The corporate had reported gross sales from operations at Rs 8,464 crore within the year-ago interval.
Through the interval underneath evaluation, the corporate mentioned it incurred a one-time value of Rs 56.35 crore for restructuring operations in sure nations.
Whole loss cited as an distinctive merchandise through the fourth quarter, stood at Rs 3,936 crore.
[ad_2]